Serco Group Plc has acquired Northrop Grumman's mission training and satellite ground network software business for $327M, expanding its US defense market reach...
Future plc (LON: FUTR) appoints Kevin Li Ying as CEO from March 2025, following Jon Steinberg’s tenure, marking a new era for the digital media leader...
REACT Group Plc reports robust growth, achieving a 6% rise in organic revenue and an 87% recurring revenue base, with strategic plans for further expansion...
St. James's Place plc reports record funds under management of £190.2 billion for 2024, driven by strong client investments and high retention rates...
Nuformix plc (LON:NFX) raises £168,750 for fibrosis drug development through a new share placing, advancing its NXP002 programme and corporate goals...
HOOKIPA Pharma and Poolbeg Pharma enter talks for a potential acquisition aimed at developing next-generation immunotherapies for critical medical needs...
Strix Group Plc sees FY24 profits surpass expectations, driven by innovation and strong market presence, with new product launches fueling future growth...
Serco Group Plc has acquired Northrop Grumman's mission training and satellite ground network software business for $327M, expanding its US defense market reach...
Future plc (LON: FUTR) appoints Kevin Li Ying as CEO from March 2025, following Jon Steinberg’s tenure, marking a new era for the digital media leader...
REACT Group Plc reports robust growth, achieving a 6% rise in organic revenue and an 87% recurring revenue base, with strategic plans for further expansion...
St. James's Place plc reports record funds under management of £190.2 billion for 2024, driven by strong client investments and high retention rates...
Nuformix plc (LON:NFX) raises £168,750 for fibrosis drug development through a new share placing, advancing its NXP002 programme and corporate goals...
HOOKIPA Pharma and Poolbeg Pharma enter talks for a potential acquisition aimed at developing next-generation immunotherapies for critical medical needs...
Strix Group Plc sees FY24 profits surpass expectations, driven by innovation and strong market presence, with new product launches fueling future growth...
